You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 69918-0201


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 69918-0201

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 69918-0201

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number assigned by the FDA to identify drug products. This code includes the labeler code, product code, and package code, providing a comprehensive identifier for each drug product[1][5].

Identifying the Drug

The NDC 69918-0201 can be broken down as follows:

  • Labeler Code: 69918
  • Product Code: 0201
  • Package Code: Specific to the package size and type

This code identifies a specific drug product, including its strength, dosage form, and formulation, as well as the package size and type.

Market Context

Pharmaceutical Industry Trends

The pharmaceutical industry is undergoing significant transformations, driven by advancements in technology, regulatory shifts, and evolving market dynamics. Trends such as the continued dominance of small molecule drugs, increasing adoption of biologics, and the growing demand for personalized medicine are shaping the industry[3].

Drug Pricing Dynamics

Drug price increases are a common phenomenon in the U.S. pharmaceutical market. Between 2017 and 2023, list prices for prescription drugs saw significant increases, with an average price increase of 15.2% in 2023 alone. This trend indicates that drug prices are subject to frequent adjustments, often exceeding inflation rates[4].

Price Projections

Historical Price Trends

To project the price of the drug with NDC 69918-0201, it is essential to analyze historical price trends. For many drugs, list prices have increased substantially over the years. For example, between 2018 and 2023, nine out of ten drugs selected for Medicare Part D price negotiations saw list price increases ranging from 20% to 55%[2].

Negotiated Prices and Discounts

The Medicare Drug Price Negotiation Program, set to begin in January 2026, will significantly impact drug prices. Negotiated prices for selected drugs have resulted in discounts ranging from 38% to 79% compared to list prices. This indicates that future price projections may need to account for potential negotiated prices and discounts[2].

Regulatory and Market Factors

Regulatory changes and market dynamics can also influence drug prices. For instance, the inclusion of compounded drug products in the NDC Directory, as well as changes in regulatory requirements, can affect pricing strategies. Outsourcing facilities, which may assign NDCs to their compounded products, must comply with specific reporting requirements, which could impact their pricing models[1].

Market Analysis

Demand and Usage

Understanding the demand and usage patterns of the drug is crucial for market analysis. For example, if the drug treats a common condition like cardiovascular disease, diabetes, or cancer, it is likely to have a high demand. The number of patients using the drug and the total costs associated with it can provide insights into its market impact[2].

Competitive Landscape

The competitive landscape of the pharmaceutical industry is another key factor. The presence of generic or biosimilar alternatives can significantly impact the pricing of branded drugs. Additionally, the expiration of patents and the entry of new competitors can lead to price adjustments[3].

Key Takeaways

  • NDC Significance: The NDC is a critical identifier for drug products, providing detailed information about the labeler, product, and package.
  • Historical Price Trends: Drug prices have seen significant increases over the years, often exceeding inflation rates.
  • Negotiated Prices: Future price projections should consider potential negotiated prices and discounts, especially with programs like Medicare Part D.
  • Regulatory Impact: Changes in regulatory requirements and market dynamics can influence pricing strategies.
  • Demand and Competition: Understanding demand and the competitive landscape is essential for accurate market analysis and price projections.

FAQs

  1. What does the National Drug Code (NDC) represent?

    • The NDC is a unique, three-segment number that identifies a drug product, including the labeler, product, and package code[1][5].
  2. How do historical price trends affect future price projections?

    • Historical price trends, such as frequent and significant list price increases, can indicate potential future price adjustments and should be considered in projections[4].
  3. What impact do negotiated prices have on drug pricing?

    • Negotiated prices, such as those under the Medicare Drug Price Negotiation Program, can result in significant discounts compared to list prices, affecting future pricing strategies[2].
  4. How does the competitive landscape influence drug pricing?

    • The presence of generic or biosimilar alternatives and changes in patent status can lead to price adjustments as companies respond to market competition[3].
  5. What role do regulatory changes play in drug pricing?

    • Regulatory changes, such as those affecting compounded drug products or reporting requirements, can impact pricing models and strategies[1].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Medicare Drug Price Negotiation Program - ASPE - HHS.gov
  3. Top 12 Pharmaceutical Industry Trends in 2024 - Global Pharma Tek
  4. Changes in the List Prices of Prescription Drugs, 2017-2023 - ASPE
  5. National Drug Code Database Background Information - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.